Back to Results
First PageMeta Content
Tyrosine kinase receptors / Trastuzumab / HER2/neu / Anatomical pathology / Stomach cancer / Breast cancer / Immunohistochemistry / Epidermal growth factor receptor / Biology / Anatomy / Medicine


Public Summary Document Application No[removed]Assessment of HER2 gene amplification for use of trastuzumab in gastric cancer Sponsor/Applicant/s: Roche Products Pty Limited
Add to Reading List

Document Date: 2014-11-06 23:49:27


Open Document

File Size: 697,05 KB

Share Result on Facebook

City

immunohistochemistry The ToGA / /

Company

IHC / Roche Products Pty Limited / FISH Abbreviations / GE / /

Country

Australia / /

Currency

USD / /

Event

Business Partnership / /

Facility

Royal College of Pathologists / /

IndustryTerm

health technology / clinical management algorithms / co-dependent technology / clinical management / treatment of their metastatic gastric cancer / /

MedicalCondition

advanced stage disease / gastric cancer / cancer / advanced adenocarcinoma / disease / gastric cancers / unique gastric cancer / previously untreated advanced gastric cancer / early and late stage breast cancer / tumour / metastatic disease / metastatic gastric cancer / drug usage / metastases / advanced gastric cancer / breast cancer / /

MedicalTreatment

chemotherapy / intravenous infusion / /

Organization

Pharmaceutical Benefits Advisory Committee / Royal College of Pathologists of Australasia / Department of Health / National Association of Testing Authorities / Medicare / /

/

Position

pathologist / /

Product

Herceptin / cisplatin / /

Technology

health technology / gene amplification / chemotherapy / clinical management algorithms / co-dependent technology / /

SocialTag